Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Pediatrics
Published in: Indian Journal of Pediatrics 2/2014

01-02-2014 | Symposium on Pediatric Endocrinology

Management of Type 1 Diabetes in Children and Adolescents

Author: Vandana Jain

Published in: Indian Journal of Pediatrics | Issue 2/2014

Login to get access

Abstract

Type 1 diabetes (T1D) is estimated to have a prevalence of approximately 1 in 5000 among Indian children. Living with T1D is a challenge for the child and the family because of the significant burden of treatment in terms of regular injections and monitoring of blood sugar, and risk of acute and long term complications that this condition imposes. Optimal glycemic control in T1D requires a meticulous balance of insulin therapy with diet and exercise. With the earlier insulin regimens this required lot of discipline in the eating and activity pattern, which led to significant curtailment of the lifestyle. Now, with availability of better insulins, delivery and monitoring devices, greater flexibility in lifestyle has become possible. The ultimate breakthrough in terms of therapy of T1D shall be easy availability of accurate and affordable closed loop systems, and ‘cure’ through islet or stem cell transplant. A review of the ambulatory management of T1D in children and adolescents and the upcoming therapeutic advances is being presented in this paper.
Literature
1.
Raha O, Chowdhury S, Dasgupta S, Raychaudhuri P, Sarkar BN, Raju PV, et al. Approaches in type 1 diabetes research: A status report. Int J Diabetes Dev Ctries. 2009;29:85–101.PubMedCentralPubMedCrossRef
2.
3.
Gan MJ, Albanese-O'Neill A, Haller MJ. Type 1 diabetes: Current concepts in epidemiology, pathophysiology, clinical care, and research. Curr Probl Pediatr Adolesc Health Care. 2012;42:269–91.PubMedCrossRef
4.
The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.CrossRef
5.
Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53.
6.
Hypoglycemia in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes. 1997;46:271–86.
7.
Mehta SN, Wolfsdorf JI. Contemporary management of patients with type 1 diabetes. Endocrinol Metab Clin N Am. 2010;39:573–93.CrossRef
8.
Vajo Z, Fawcett J, Duckworth WC. Recombinant DNA technology in the treatment of diabetes: Insulin analogs. Endocr Rev. 2001;22:706–17.PubMedCrossRef
9.
Galli-Tsinopoulou A, Stergidou D. Insulin analogues for type 1 diabetes in children and adolescents. Drugs Today (Barc). 2012;48:795–809.
10.
Danne T. Flexibility of rapid-acting insulin analogues in children and adolescents with diabetes mellitus. Clin Ther. 2007;29:S145–52.PubMedCrossRef
11.
Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis. Diabetes Obes Metab. 2009;11:372–8.PubMedCrossRef
12.
Chase HP, Arslanian S, White NH, Tamborlane WV. Insulin glargine versus intermediate -acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus. J Pediatr. 2008;153:547–53.PubMedCrossRef
13.
14.
Tamborlane WV, Sikes KA. Insulin therapy in children and adolescents. Endocrinol Metab Clin N Am. 2012;41:145–60.CrossRef
15.
Bangstad HJ, Danne T, Deeb L, Jarosz-Chobot P, Urakami T, Hanas R. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2009;10:82–99.PubMedCrossRef
16.
17.
Kordonouri O, Hartmann R, Danne T. Treatment of type 1 diabetes in children and adolescents using modern insulin pumps. Diabetes Res Clin Pract. 2011;93:S118–24.PubMedCrossRef
18.
Haller MJ, Stalvey MS, Silverstein JH. Predictors of control of diabetes: Monitoring may be the key. J Pediatr. 2004;144:660–1.PubMedCrossRef
19.
Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, et al. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes. 2009;10:71–81.PubMedCrossRef
20.
Szypowska A, Ramotowska A, Dzygalo K, Golicki D. Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: Systematic review and meta-analysis of randomized trials. Eur J Endocrinol. 2012;166:567–74.PubMedCrossRef
21.
Laffel LM, Wentzell K, Loughlin C, Tovar A, Moltz K, Brink S. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: A randomized clinical trial. Diabet Med. 2006;23:278–84.PubMedCrossRef
22.
Smart C, Aslander-van Vliet E, Waldron S. Nutritional management in children and adolescents with diabetes. Pediatr Diabetes. 2009;10:100–17.PubMedCrossRef
23.
Wolever TM, Hamad S, Chiasson JL, Josse RG, Leiter LA, Rodger NW, et al. Day-to-day consistency in amount and source of carbohydrate associated with improved blood glucose control in type 1 diabetes. J Am Coll Nutr. 1999;18:242–7.PubMedCrossRef
24.
DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: Dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ. 2002;325:746–52.PubMedCentralCrossRef
25.
Brink S, Laffel L, Likitmaskul S, Liu L, Maguire AM, Olsen B, et al. Sick day management in children and adolescents with diabetes. Pediatr Diabetes. 2009;10:146–53.PubMedCrossRef
26.
Laffel L. Sick-day management in type 1 diabetes. Endocrinol Metab Clin N Am. 2000;29:707–23.CrossRef
27.
Sivanandan S, Sinha A, Jain V, Lodha R. Management of diabetic ketoacidosis. Indian J Pediatr. 2011;78:576–84.
28.
Workgroup on Hypoglycaemia, ADA. Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care. 2005;28:1245–9.CrossRef
29.
Clarke W, Jones T, Rewers A, Dunger D, Klingensmith GJ. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2009;10:134–45.PubMedCrossRef
30.
Cryer PE. Hypoglycemia: The limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia. 2002;45:937–48.PubMedCrossRef
31.
Georgakopoulos K, Katsilambros N, Fragaki M, Poulopoulou Z, Kimbouris J, Sfikakis P, et al. Recovery from insulin-induced hypoglycemia after saccharose or glucose administration. Clin Physiol Biochem. 1990;8:267–72.PubMed
32.
Welch IM, Bruce C, Hill SE, Read NW. Duodenal and ileal lipid suppresses postprandial blood glucose and insulin responses in man: Possible implications for the dietary management of diabetes mellitus. Clin Sci (Lond). 1987;72:209–16.
33.
Aman J, Wranne L. Hypoglycemia in childhood diabetes. Effect of subcutaneous or intramuscular injection of different doses of glucagon. Acta Paediatr Scand. 1988;77:548–53.PubMedCrossRef
34.
Miculis CP, Mascarenhas LP, Boguszewski MC, Campos W. Physical activity in children with type 1 diabetes. J Pediatr (Rio J). 2010;86:271–8.
35.
Pihoker C, Forsander G, Wolfsdorf J, Klingensmith GJ. The delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatr Diabetes. 2009;10:58–70.PubMedCrossRef
36.
37.
38.
Jain V, Jain R. Severe limited joint mobility syndrome in a child with type 1 diabetes mellitus. Indian J Pediatr. 2012;79:959–60.PubMedCrossRef
39.
Setoodeh A, Mostafavi F, Hedayat T. Glycemic control in Iranian children with type 1 diabetes mellitus: Effect of gender. Indian J Pediatr. 2012;79:896–900.PubMedCrossRef
40.
41.
Metadata
Title
Management of Type 1 Diabetes in Children and Adolescents
Author
Vandana Jain
Publication date
01-02-2014
Publisher
Springer India
Published in
Indian Journal of Pediatrics / Issue 2/2014
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-013-1196-3

Other articles of this Issue 2/2014

Indian Journal of Pediatrics 2/2014 Go to the issue

Scientific Letter

Human Milk Banks and their Relevance in India

Symposium on Pediatric Endocrinology

Type 2 Diabetes Mellitus in Children and Adolescents

Original Article

Disseminated Staphylococcal Disease in Healthy Children—Experience from Two Tertiary Care Hospitals of West Bengal

Symposium on Pediatric Endocrinology

Cushing Syndrome

Scientific Letter to the Editor

Swine Flu Presenting as Acute Appendicitis

Scientific Letter to the Editor

A Case of Rabies after Squirrel Bite